Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 1 |
2011 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosis.
Schizophr Bull. 2011 Sep;37 Suppl 2:S111-21. doi: 10.1093/schbul/sbr083.
Schizophr Bull. 2011.
PMID: 21860040
Free PMC article.
Clinical Trial.
[Early recognition centres for patients at risk of developing schizophrenia in Germany].
Sahlmann MM, Vieten AB, Sheldrick AJ, Haeck M, Schneider F, Michel TM.
Sahlmann MM, et al.
Gesundheitswesen. 2010 Nov;72(11):771-5. doi: 10.1055/s-0029-1242783. Epub 2010 Jan 4.
Gesundheitswesen. 2010.
PMID: 20049679
German.
Item in Clipboard
Cite
Cite